The Role of Pharmacists in Supporting Patients on GLP-1 Therapy

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly utilized in the management of obesity and type 2 diabetes due to their effectiveness in reducing appetite and promoting weight loss. However, these medications can lead to gastrointestinal adverse effects, such as nausea and vomiting, which may hinder nutrient intake and exacerbate existing micronutrient deficiencies. Notably, populations with obesity and diabetes often exhibit high rates of deficiencies in essential nutrients, including vitamin D, vitamin C, and selenium. As a result, healthcare professionals, particularly pharmacists, are positioned to play a crucial role in addressing these nutritional challenges.

Beyond the Scale: The Pharmacist’s Role in Preserving Patients’ Muscle and Nutrition During GLP-1 Therapy

Research indicates that weight loss associated with GLP-1 therapy may include a reduction in lean muscle mass, which is critical for maintaining metabolic health. To mitigate muscle loss, a protein intake of 1.2 to 2.0 grams per kilogram of body weight per day is recommended. Despite this, only about 43% of patients on GLP-1 therapy meet their minimum protein requirements. Pharmacists can encourage patients to achieve their protein goals by recommending high-quality protein sources, such as lean meats, legumes, and dairy products. Additionally, combining adequate protein intake with resistance training has been shown to significantly enhance muscle strength.

Beyond the Scale: The Pharmacist’s Role in Preserving Patients’ Muscle and Nutrition During GLP-1 TherapyThink it’s too late to lose weight? Doctors say one overlooked habit can restart your metabolism and transform your healthEatingWellWoman's WorldDeepika Padukone’s trainer shares one healthy snack you should add to your daily diet for weight management. What is it?Lost 28 kg weight, lowered BP, and improved sleep: Hyderabad neurologist shares his 3 weight-loss secrets

Pharmacists should also monitor for micronutrient gaps, as deficiencies can lead to fatigue, reduced immune function, and poor glycemic control. A 2025 multisociety advisory from leading nutrition and obesity organizations recommends that patients starting GLP-1 therapy undergo a baseline nutrition and micronutrient assessment. This proactive approach allows for early identification of deficiencies and the development of tailored dietary recommendations.

Beyond the Scale: The Pharmacist’s Role in Preserving Patients’ Muscle and Nutrition During GLP-1 TherapyEatingWellGenetic Literacy ProjectWoman's World

The Mediterranean diet, characterized by an abundance of whole grains, fruits, vegetables, nuts, legumes, olive oil, and fish, has demonstrated cardiovascular benefits that complement GLP-1 therapy. Studies, including the landmark PREDIMED trial, have shown significant reductions in major cardiovascular events among individuals adhering to this dietary pattern. Pharmacists can promote the Mediterranean diet as a means to enhance weight loss, improve glycemic control, and support overall metabolic health during GLP-1 therapy.

Beyond the Scale: The Pharmacist’s Role in Preserving Patients’ Muscle and Nutrition During GLP-1 TherapyThink it’s too late to lose weight? Doctors say one overlooked habit can restart your metabolism and transform your healthWoman's WorldGenetic Literacy ProjectEatingWellDeepika Padukone’s trainer shares one healthy snack you should add to your daily diet for weight management. What is it?

Pharmacists are encouraged to reinforce the importance of adequate protein intake and micronutrient monitoring among patients undergoing GLP-1 therapy. By integrating nutritional assessments into their practice, pharmacists can bridge the gap between pharmacologic treatment and sustainable lifestyle changes, ultimately maximizing the benefits of GLP-1 therapy while supporting long-term health.

Beyond the Scale: The Pharmacist’s Role in Preserving Patients’ Muscle and Nutrition During GLP-1 Therapy

Despite the potential benefits of GLP-1 therapy, some critics argue that reliance on medications without adequate nutritional support may lead to preventable health issues, including muscle loss and nutrient deficiencies. There is a call for a more holistic approach that emphasizes the integration of pharmacotherapy with comprehensive dietary and lifestyle modifications.

Beyond the Scale: The Pharmacist’s Role in Preserving Patients’ Muscle and Nutrition During GLP-1 Therapy

• “Asking about dietary intake during counseling and recommending appropriate laboratory testing or supplements can help bridge these gaps.” — Abigail Knapp, BSPS

Beyond the Scale: The Pharmacist’s Role in Preserving Patients’ Muscle and Nutrition During GLP-1 Therapy

In conclusion, the role of pharmacists in supporting patients on GLP-1 therapy is vital for ensuring optimal health outcomes. By focusing on protein intake, monitoring micronutrient deficiencies, and promoting evidence-based dietary patterns, pharmacists can significantly enhance the effectiveness of GLP-1 therapy and contribute to the overall well-being of their patients.

Beyond the Scale: The Pharmacist’s Role in Preserving Patients’ Muscle and Nutrition During GLP-1 Therapy